Additionally, transcript levels of GFAPΔEx6 and GFAPΔ164 have been detected in both cognitively unimpaired individuals and AD patients, suggesting that certain GFAP isoforms are expressed before the onset of clinical symptoms [150]. Here, GFAP is linked to Alzheimer disease.